simvastatin 20-40 mg (Grundy SM, et al.J Am Coll Cardiol. 2019;10a) is recommended for intermediate risk patients (≥ 7.5%-< 20%) if ASCVD risk “enhancers” are present. Statins are recommended for patients whose 10-year ASCVD risk if 20% or higher. A high-intensi...